Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer? Journal Article
| Author: | Dalbagni, G. |
| Article Title: | Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer? |
| Keywords: | cancer chemotherapy; treatment outcome; clinical trial; cancer recurrence; cancer growth; cancer risk; drug efficacy; bcg vaccine; risk factors; editorial; bladder cancer; urinary bladder neoplasms; mitomycin c; cystitis; adjuvants, immunologic; administration, intravesical; antibiotics, antineoplastic; mitomycin |
| Journal Title: | European Urology |
| Volume: | 56 |
| Issue: | 2 |
| ISSN: | 0302-2838 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2009-08-01 |
| Start Page: | 257 |
| End Page: | 258 |
| Language: | English |
| DOI: | 10.1016/j.eururo.2009.04.041 |
| PUBMED: | 19427109 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 3" - "Export Date: 30 November 2010" - "CODEN: EUURA" - "Source: Scopus" |
